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Springfield, Ill
Objective:To prospectively evaluate complications after diagnostic and therapeutic endovascular procedures (DTEPs) and
determine what factors are predictive.
Methods: From December 2002 to December 2003, all patients undergoing DTEPs performed by university vascular
surgeons in a catheterization laboratory were prospectively evaluated. Medical demographics, procedure-related details,
and type and severity of complications were recorded at the time of the procedure, during the first 24 hours, and at 2 to
4 weeks. Complications were classified as local vascular (LV), local nonvascular (LNV), systemic remote (SR), and major,
minor, and nonsignificant.
Results: Three hundred-three DTEPs were performed (54.5% DEPs, 45.5% TEPs). At the time of DTEP, 28 complica-
tions occurred in 23 patients: 10 LV (3.3%), 15 LNV (5.0%), and 3 SR (1.0%). At 24 hours, 26 complications occurred
in 25 patients: 5 LV (1.7%), 7 LNV (2.3%), and 14 SR (4.7%). At 2 to 4 weeks, 26 complications occurred 25 patients:
5 LV (1.7%), 7 LNV (2.3%), and 14 SR (4.7%). The combined major (7.3%) and minor (4.3%) complication rate
attributed to DTEPs was 11.6%. Significant predictors (P < .05) by multivariate analysis included thrombolysis, prior
stroke, an additional procedure during the study period, and diabetes mellitus (odds ratios: 9.1, 3.2, 2.7, and 2.4,
respectively).
Conclusion: According to newly applied reporting standards, the prospective evaluation of DTEPs reveals that compli-
cations are uniformly distributed by type and follow-up period. Just over 1 in 10 patients will suffer either a major or
minor complication. Potential predictors have been identified that may assist in patient selection and treatment plans to
lower complications resulting from DTEPs. (J Vasc Surg 2004;40:1142-8.)The evolution of endovascular therapy in treating vas-
cular pathology has fueled the transition of vascular surgery
into a new era. As a result, an ever-increasing number of
vascular surgeons are now treating peripheral vascular dis-
ease with a new armamentarium of catheters, guidewires,
angioplasty balloons, and stents. Moreover, recent reports1
have predicted that 50% to 90% of all invasive vascular
treatments in the near future will involve some endovascu-
lar component.
Given that vascular surgeons and other specialties are
active in performing complex diagnostic and therapeutic
endovascular procedures (DTEPs), the measurement of
outcomes becomes paramount to providing the highest
standards of patient care. Complications after DTEPs rep-
resent one important form of outcomemeasurement. Iron-
ically, little work has been done to examine the complica-
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1142tions that occur as a result of these procedures. Vascular
surgeons, long committed to this patient population, have
previously established reporting standards for procedural
complications.2-5 This study defines the scope and com-
plexity of DTEPs performed by vascular surgeons, as well as
an in-depth prospective evaluation of the complications
that occurred as a result of these procedures.
PATIENTS AND METHODS
The study group consisted of consecutive patients who
underwent DTEPs performed by vascular surgeons be-
tween December 2002 and December 2003. All vascular
surgeons were board certified and full-time faculty in the
Division of Vascular Surgery at Southern Illinois Univer-
sity, Springfield, Ill. DTEPs were performed at two tertiary
care centers, Memorial Medical Center (MMC) or St.
John’s Hospital (SJH). The combined experience for the
full-time faculty (RBM, KJH) who performed the DTEPs
was 21 years. No DTEPs were referred to other endovas-
cular or interventional specialists. DTEPs were performed
with digital subtraction angiography either in an endovas-
cular suite (MMC) using a Phillips Integris Type 987
(Hamburg, Germany) unit with a variable 15-inch image
intensifier or in an interventional radiology suite (SJH)
using a Seimens Multistar T.O.P.S. (Munich, Germany)
unit.
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the exception of aortic endograft implantation and comple-
tion arteriography after open surgery, were included in this
study. The method of primary post-DTEP hemostasis dif-
fered between hospitals. MMC personnel were trained to
use manual pressure, whereas SJH personnel placed a C-
clamp compression device (Instromedix, Hillsboro, Ore).
Further need for prolonged device compression (Femo-
Stop plus, RadiMedical Systems, Reading,Mass) was at the
discretion of the attending vascular surgeon. Data were
prospectively collected by either the vascular attending or
vascular fellow and entered into a database (Microsoft
Access for Windows, Redmond, Wash).
Patient-related data included demographics, risk fac-
tors, procedure indications, and type and urgency of
DTEP. DTEP-related data included trainee involvement,
site and type of access, the number and sites of selective
cannulation, whether a concomitant TEP was performed,
type and amount of contrast, fluoroscopy time, anticoagu-
lation or additional medications administered during the
procedure, and the method of postprocedure hemostasis.
Follow-up data for complications were obtained at
three time periods. Patients were evaluated during and
immediately after the procedure (immediate period), dur-
ing the first 24 hours (early period), and at 2 to 4 weeks
(delayed period) by either telephone questionnaire or by
physical examination. Complications were categorized into
local vascular (LV), local nonvascular (LNV), and system-
ic/remote (SR) based on the ad hoc committee on report-
ing standards recommendations by vascular surgeons.2,5
Complication severity was categorized as major, minor,
and nonsignificant as previously described by Egglin et al.6
Complications were categorized as major if operative or
endovascular repair was necessary, permanent morbidity
resulted, or the patient required dialysis or blood transfu-
sion. Minor complications included immediately correct-
able events requiring additional, unexpected therapy. Non-
significant complications were adverse occurrences, such as
groin ecchymosis, that required no additional interventions
and did not alter the patient’s hospital course. This study
was approved by the Institutional Review Board at South-
ern Illinois University (SIU).
Statistical analysis. Statistical analysis was performed
by the SIU Department of Statistics (coauthor SJM) using
Statistical Analysis Systems (SAS) software (Cary, NC). For
each category of complications, the McNemar test of cor-
related proportions was used to determine significant
changes across the three time periods, to compare rates of
complications at each time period, and to compare major,
minor, and nonsignificant complications between the three
time periods. The different continuousmeasures of patients
with and without complications, as well as those patients
who underwent a therapeutic procedure versus a diagnostic
procedure, were compared with t tests. Additionally, the 2
test of independence or the Fisher exact test was performed
to determine the univariate significance of patient-related
or procedure-related variables to complications. A logistic
regression model was used to determine the multivariatesignificance of procedure related variables to complications.
Data is expressed as a mean  standard deviation. P .05
was accepted as statistically significant.
RESULTS
Three hundred-three DTEPs were performed in 261
patients (61% men) with a mean age of 66 years (range, 16
to 93). Thirty-six patients underwent 2 DTEPs, and 3
patients had 3 DTEPs. Patient comorbidities are described
in Appendix I (online only). Twenty-three patients (7.6%)
were being treated with clopidogrel at the time of the
procedure, and 201 (66.3%) were taking aspirin. Warfarin
was discontinued 3 days prior to most DTEPs, and the
mean international normalized ratio of all patients was 1.7
(range, 0.9 to 2.8). Eighty patients (26.4%) had a serum
creatinine level of 1.5 mg/dL or more. Excluding patients
with end-stage renal disease, the mean baseline serum
creatinine level was 1.1 mg/dL (range, 0.4 to 4.5 mg/dL).
Procedure-related demographics are described in Appendix
II (online only). Attending surgeons were present, but not
scrubbed, for 36% of DTEPs.
One hundred sixty-five (54.5%) DEPs were performed.
This included 115 (69.7%) aorta-iliac-femoral arteriogra-
phy with or without lower extremity arteriography (AIF),
34 (20.6%) arch aortography with carotid or upper extrem-
ity arteriography (AA) (or both), 9 (5.5%) venous, 5 (3.0%)
dialysis, and 7 (4.2%) renal/mesenteric DEPs. Five patients
(3.0%) had more than one type of DEP performed. One
hundred thirty-eight (45.5%) TEPs were performed. Indi-
cations for AIF and AA studies duringDTEPs are described
in Appendix III (online only). Most of the venous studies
(86.2%) were performed in conjunction with venocaval
filter insertion (23) or the removal of retrievable filters (2).
Three venous studies (10.3%) were performed in the eval-
uation and treatment of central stenosis.
TEPs were performed in 138 patients. Balloon angio-
plasty was performed in 106 TEPs (35%), 1.53  0.83
vessels were dilated per patient (range, 1 to 4 per patient).
Stent deployment, which included placement of 5 covered
stents, was performed in 65 (21.5%) TEPs. Stenting was
primary (without balloon pre-dilatation) in 22 patients
(33.8%), followed suboptimal angioplasty in 30 patients
(46.2%), and followed balloon pre-dilatation in 13 patients
(20.0%). Thrombolysis was performed in 11 patients
(3.6%) in whom 7 (2.3%) had chemical and 9 (3.0%) had
mechanical (5 patients were treated with both mechanical
and chemical lysis). Table I lists these TEP sites. Additional
TEPs included 2 embolization procedures (1 endoleak, 1
splenic artery aneurysm), the deployment of 23 venacaval
filters, and the removal of 2 retrievable filters.
Upon completion of DTEPs, manual pressure was ap-
plied in 248 (81.8%) DTEPs, and a C-clamp was used in 53
(17.5%) DTEPs. Prolonged device compression (Femo-
Stop plus) was applied in 34 (11.2%) DTEPs. Other pro-
cedural details, including sites cannulated, number of
sheath exchanges, types of selective catheterizations,
amount of contrast used, fluoroscopy times, and use of
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Seventy-five complications occurred during 59 DTEPs
(19.5%). In the immediate period (IP), 28 complications
were identified in 23 patients: 10 LV (3.3%), 15 LNV
(5.0%), 3 SR (1.0%) (Fig 1). Five patients had complica-
tions in more than one category, and 2 patients had two LV
complications during this time period. The rate of SR
complications was lower during this time period than LV
(1.0% vs 3.3%, P  .034) and LNV (1.0% vs 5.0%, P 
.005).
LV complications were embolic in 2 patients (1 was
successfully treated with thrombolysis; 1 required a graft
revision after thrombolysis failed), 1 dissection treated with
stent placement; vascular thrombosis successfully repaired
at operation in 4 patients (brachial artery in 2, common
femoral artery in 1, bypass graft in 1); transfusion in 1
patient with preprocedural anemia after thrombolysis; and
treatment failure in 2 patients after angioplasty and throm-
bolysis. LNV complications (15 patients) were all signifi-
cant ecchymosis/hematoma. SR complications included
vasovagal reactions in 2 patients and an allergic reaction to
analgesia in 1 patient.
In the early period (EP), 21 complications were ob-
served in 19 patients: 8 LV (2.6%), 10 LNV (3.3%), and 3
SR (1.0%) (Fig 1). There was no significant difference in the
complication rates among the three groups. Two patients
experienced complications in two categories during this
time. LV complications included pseudoaneurysm forma-
tion in 3 patients (1 spontaneously thrombosed, 1 with an
arteriovenous fistula resolved, 1 required thrombin injec-
tion), and the need for blood transfusion in 5 patients. All
LNV complications (10 patients) were ecchymosis/hema-
tomas. SR complications included urinary retention in 1
patient, acute renal insufficiency in 1 patient, and death in 1
patient after cardiopulmonary arrest. This last patient was
found to be unresponsive approximately 4 hours after an
infrainguinal venous bypass angioplasty. Although death
was attributed to a cardiac cause, other etiologies from
Table I. Distribution of intervention sites treated with
therapeutic endovascular procedures
Intervention site
PTA
procedures
(%)
Stent
procedures
(%)
Thrombolysis
procedures
(%)
Suprainguinal arterial system42 (13.9) 27 (8.9) 6 (2.0)
Infrainguinal arterial system 16 (5.3) 12 (4.0) 8 (2.6)
Crural arteries 2 (0.7) 1 (0.3) 0
Bypass graft 13 (4.3) 3 (1.0) 5 (1.7)
Carotid/subclavian artery 7 (2.3) 8 (2.6) 0
Axillary/brachial artery 2 (0.7) 0 0
Renal/mesenteric artery 14 (4.6) 13 (4.3) 0
SVC/innominate/subclavian
vein
8 (2.6) 1 (0.3) 0
Dialysis graft/fistula 5 (1.7) 0 0
PTA, Percutaneous transluminal angioplasty; SVC, superior vena cava.complications directly related to the DTEP cannot be ruledout. An autopsy was not performed. Two hundred thirty-
four DTEPs (77.2%) were performed as either outpatient
(128, 42.2%) or 23-hour observation (106, 35.0%).
In the delayed period (DP), 26 complications in 25
patients were identified: 5 LV (1.7%), 7 LNV (2.3%), and
14 SR (4.7%) (Fig 1). Two patients were lost to follow-up
and 1 patient died during the EP. During the DP, 109
patients (36.3%) underwent additional operative or endo-
vascular procedures. More SR complications occurred than
LV (4.7% vs 1.7%, P  .035). LV complications included
blood transfusion in 2 patients, intervention site thrombo-
sis in 2 patients (one bypass graft treated with thrombolysis
and distal revision, one renal artery left untreated), and
treatment failure (1 patient) that required repeat angio-
plasty. LNV complications included cellulitis at the punc-
ture site in 2 patients and significant ecchymosis/hema-
toma in 5 patients. SR complications included allergic
reactions in 2 patients, hypotension/sepsis in 1 patient,
congestive heart failure/respiratory distress in 6 patients,
stroke after peripheral bypass surgery in 1 patient, throm-
boembolic event from cardiac source in 1 patient, and
multisystem organ failure in 2 patients (1 occurred after a
myocardial infarction). During the DP, only 10 complica-
tions (3 LV, 7 LNV, 0 SR) were directly related to DTEPs.
Complication rates were similar between the LV (3.3%,
2.6%, and 1.7%) and LNV (5.0%, 3.3%, and 2.3%) groups
throughout the three time periods. More SR complications
were noted during the DP than during both the IP (4.7% vs
1.0%, P  .008) and the EP (4.7% vs 0.7%, P  .0013).
Twenty-eight complications were classified as major
(9.2%), 23 as minor (7.6%), and 24 as nonsignificant
(7.9%). The distribution of these classes is described in
Figure 2. No significant difference was noted between these
three categories at each time period and within categories
throughout the three time periods. The combined major
(22 patients, 7.3%) and minor (13 patients, 4.3%) compli-
cation rate attributed to DTEPs was 11.6%.
Multiple factors in the univariate analysis were shown
to affect complication rates (Table II). LV complications
were noted more often in those patients who underwent
thrombolysis, required sheath exchange, required access
with a sheath greater than 5F, underwent additional inva-
sive procedures over the subsequent 2 to 4 weeks, and had
a prior history of stroke. Conversely, patients who had
manual pressure and same-day procedures were signifi-
cantly less likely to have LV complications. LNV complica-
tions were more frequent after brachial access and in pa-
tients who were treated with balloon angioplasty. SR
complications were seen more frequently in smokers and in
patients who required additional invasive procedures over
the study period. The rate of overall complications was
increased after brachial access, thrombolysis, in patients
who underwent additional procedures, and if there had
been a prior stroke. Patients who had right femoral access
and same-day procedures were significantly less likely to
have any type of complication.
Multivariate analysis (Table III) of factors demon-
strated an increased LV complication rate in patients with
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those treated with thrombolysis. Patients who had manual
Fig 1. Number of local vascular (LV), local nonvasc
diagnostic and therapeutic endovascular procedures (DT
time periods. †SR (D) SR (IP) (P .008) and SR (EP
 IP (LV) (P  .034) and IP (LNV) (P  .005).
Fig 2. Number of: major, minor, and nonsignificant (N
procedures (DTEP) during each time period. No signifi
complications at each time period. In addition, no signi
between the three time periods.pressure were significantly less likely to have LV complica-tions. LNV complications occurred more often after bal-
loon angioplasty and brachial access. SR complications
(LNV), and systemic/remote (SR) complications for
uring the immediate (IP), early (EP), and delayed (DP)
.0013); *DP (SR) DP (LV) (P 0.035);IP (SR)
mplications for diagnostic and therapeutic endovascular
differences were noted between the three categories of
differences were noted for each complication categoryular
EP) d
) (PS) co
cant
ficantoccurred more often in smokers, patients with a prior
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underwent additional procedures. Finally, the overall com-
plication rate was greater in those patients with prior stroke,
those treated with thrombolysis, and those who had addi-
tional procedures. Patients who had right femoral access
were significantly less likely to have any type of complica-
tion.
Multiple factors were associated with major and minor
complications. Factors contributing to major/minor com-
plications included thrombolysis, diabetes mellitus, prior
Table II. Factors associated with risk of defined category
and overall complications based on univariate analysis
Factor
Complication
category
Odds ratio
(95% CI) P
Increased Complications
Prior stroke LV 4.89 (1.73-13.88) .006
Any 3.50 (1.51-8.09) .005
Tobacco use SR 4.31 (1.23-15.14) .03
Brachial access LNV 3.70 (1.23-11.12) .029
Any 3.32 (1.27-8.68) .016
Sheath size  5F LV 3.43 (1.30-9.01) .016
Sheath exchange LV 3.38 (1.34-8.56) .013
PTA LNV 2.32 (1.08-4.97) .044
Thrombolysis LV 8.69 (2.32-32.49) .005
Any 3.67 (1.08-12.48) .042
Additional procedures LV 5.30 (2.00-14.0) .0005
SR 2.95 (1.11-7.85) .045
Any 2.20 (1.24-3.95) .010
Decreased Complications
Right femoral access LV 0.31 (0.11-0.88) .045
Any 0.31 (0.16-0.63) .0015
Manual pressure LV 0.37 (0.15-0.93) .043
Same-day procedure Any 0.39 (0.21-0.75) .006
Lv, Local vascular; LNV, local nonvascular; SR, systemic/remote; Any,
overall complication rate; PTA, percutaneous transluminal angioplasty.
Table III. Factors associated with risk of defined
category and overall complications based on multivariate
analysis
Factor
Complication
category
Odds ratio
(95% CI) P
Increased complications
Prior stroke LV 6.75 (2.09-21.80).05
Any 3.47 (1.44-8.36) .05
Tobacco use SR 4.17 (1.17-14.84).05
Brachial access LNV 3.76 (1.23-11.50).05
Any 3.14 (1.17-8.43) .05
Sheath exchange LV 3.32 (1.23-8.97) .05
PTA LNV 2.34 (1.09-5.06) .05
Thrombolysis LV 14.03 (3.06-
64.35)
.05
Additional procedures SR 3.09 (1.15-8.32) .05
Any 2.12 (1.17-3.86) .05
Decreased Complications
Right femoral access Any 0.39 (0.186-0.80).05
Manual pressure LV 0.19 (0.06-0.54) .05
LV, Local vascular; LNV, local non-vascular; SR, systemic/remote; Any,
overall complication rate; PTA, percutaneous transluminal angioplasty.stroke, and additional procedures. Factors less likely to beassociated with major/minor complications included out-
patient procedures and right femoral access (Table IV).
Five patients (1.7%) died during the study. One patient
in the EP arrested 4 hours after a TEP. During the DP, 2
patients died of multisystem organ failure, 1 of metastatic
cancer, and 1 of unknown causes. None of the deaths were
attributed to DTEPs.
DISCUSSION
This study represents the first prospective in-depth
analysis of factors contributing to complications after
DTEPs. Data were collected at three time periods (imme-
diate, early, and delayed) up to 2 to 4 weeks in an effort to
gather all complications due to DTEPs. Additionally, these
complications were classified using the method recom-
mended for vascular surgeons by the ad hoc committee on
reporting standards.2,3 This nomenclature classifies com-
plications as local vascular (LV), local nonvascular (LNV),
and systemic related (SR). Furthermore, the severity of
complications that followed DTEPs were classified as ma-
jor, minor, or nonsignificant as described by Egglin et al.6
Overall, 59 patients experienced 75 complications, 59
(79%) of which were attributed to DTEPs. The severity of
these complications was 9.2% major, 7.6% minor, and 8.6%
nonsignificant.
In reporting the number of complications that oc-
curred during the follow-up period after DTEPs—but that
were not necessarily due to DTEPs—we have attempted to
give a more accurate representation of what happens in an
academic vascular surgery practice when DTEPs are per-
formed by vascular surgeons and trainees. Herein lies the
challenge to the classic reporting of complications within
30 days after DTEPwhen an additional operation is needed
or systemic disease results in a complication (eg, cancer
death after an inferior vena cava filter placement) during the
same time frame. In this cohort, 26 complications occurred
in the 105 patients who had operations; 16 complications
Table IV. Factors associated with risk of major/minor
complications based on univariate and multivariate
analysis
Factor
Analysis
type
Odds ratio
(95% CI) P
Increased complications
Thrombolysis Univariate 5.57 (1.62-19.12) .011
Multivariate 9.06 (2.26-36.27) .05
DM Univariate 2.23 (1.16-4.30) .022
Multivariate 2.38 (1.14-4.96) .05
CVA Univariate 3.78 (1.56-9.16) .005
Multivariate 3.15 (1.16-8.54) .05
Additional procedures Univariate 2.60 (1.34-5.04) .007
Multivariate 2.65 (1.30-5.41) .05
Decreased complications
Same-day procedure Univariate 0.42 (0.20-0.87) .026
Right femoral access Univariate 0.31 (0.14-0.68) .005
DM, diabetes mellitus; CVA, cerebrovascular accident.during the DP were clearly unrelated to DTEPs.
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factors contributing to an increased risk of complication.
Previous authors have documented increased complication
rates with the use of larger catheters,7,8 transaxillary ac-
cess,9 a history of congestive heart failure,6 tobacco use,7
physician experience,7 and procedures performed in train-
ing centers.8 Interestingly, the authors did not observe an
increased complication rate in patients with a congestive
heart failure history and level of training.
New risk factors prospectively identified from this study
when analyzed by complication type or severity included
prior stroke, sheath exchanges, and diabetes mellitus.
Thrombolysis was associated with a 14-fold increase in
complication risk, which further illustrates the potential
morbidity caused by these types of TEPs.
Of interest was that right femoral access and manual
pressure after the completion of DTEPs were observed as
protective against complications. The former may be re-
lated to the ease of access, whereas left femoral access from
the right may be more difficult. The findings regarding
manual pressure versus C-clamp are important as they
directly compare two different hospital methods in our
practices. Of note, closure devices were not used after
DTEPs and, given the results of manual pressure, are
probably not indicated in most circumstances.
Another interesting aspect regarding the occurrence of
complications was the paucity of treatment failures during
and after DTEPs. We attribute this to our combined 21-
year experience with DTEPs, careful patient selection, and
perhaps the fact that vascular surgeons may have improved
insight on which types of lesions to avoid. Another reason
why treatment failures were not identified during follow-up
may be the lack of uniform testing in asymptomatic patients
or patients afflicted with a subsequent worsening medical
condition.
Previous studies describe a 2.1% to 22% complication rate
after DTEPs.6,8-13 With the exceptions of two prospective
studies,6,11 all others studies are retrospective.8-10,12,13 Of
these studies, 3 had a limited follow-upof 72hours or less,6,8,9
and 3 had follow-up ranging from 4 to 6 weeks.10,12,13
Additionally, considerable variation is observed in these stud-
ies in how complications are classified and severity defined.
Not surprisingly, the lowest complication rates are found in
those studies that are retrospective, have limited follow-up,
and lack uniformity in definition. In the prospective DTEP
study performed by interventional radiologists,11 the compli-
cation rate of 22% is comparable to our complication rate of
19.5%. More important, Young et al11 did not differentiate
complications and did not describe factors associated with
complications.
We agree with Egglin et al6 that reporting this method
of complication severity is important; however, the scope of
each category (major, minor, and nonsignificant) remains
broad and misleading. For example, the severity of ecchy-
mosis or small hematoma can vary greatly after a DTEP and
still be considered a nonsignificant complication if the
outcome is benign. Perhaps a better clarification within this
category could incorporate the development of subsequentpain or diminished patient function. Subjective patient
interpretations and objective examination after DTEPs can
significantly vary within the nonsignificant complication
category and result in misleading reporting. Clearly, the
classification systems in place for the type and severity of
complications after DTEPs in this complex patient popula-
tion need uniformity for accurate reporting of outcomes.
Although this study represents a 1-year prospective
examination of complications after DTEPs, the absolute
numbers of subcategories of different types of DTEPs
range from small to large; therefore, the complications
cannot be extrapolated to one particular type of patient
population. Nevertheless, our objective was to examine the
scope of DTEPs within the context of a vascular surgery
practice and determine which factors played a significant
role in putting patients at risk for complications.More work
is needed examining each specific area of DTEPs and their
associated unique complications. As with outcomes report-
ing of operations, vascular surgeons should continue to
critically examine their outcomes after DTEPs.
In summary, this prospective study provides the first
comprehensive examination of complications associated
with DTEPs. Moreover, the vascular surgeons performing
these procedures have applied stringent reporting standards
in an attempt to properly classify the type and severity of
complications. Important predictors were discovered that
put patients at increased risk of complications whereas
others were associated with patients less apt to suffer a
complication. All specialties performing DTEPs should
prospectively follow their patients for complications and
apply these reporting standards to further determine simi-
larities and dissimilarities. The prevention of complications
from the knowledge of cause remains a paramount first step
to safe, durable outcomes for patients undergoing DTEPs.
We thank Carol A. Buettner and Jackie P. Danetz for
their valuable help in organizing the database and assimi-
lating data.
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APPENDIX I, online only. Comorbidities of all
patients undergoing endovascular procedures
Comorbidity No. of patients %
CHF 36 11.9
Diabetes mellitus 105 34.7
Hypertension 241 79.5
Tobacco use 173 57.1
Prior stroke 26 8.6
Obesity 71 23.4
COPD 47 15.5
ESRD 38 12.5
Abnormal Cr ( 1.5) 80 26.4
Contrast allergy 21 6.9
Hypercholesterolemia 169 55.8
CHF, Congestive heart failure; COPD, chronic obstructive pulmonary
disease; ESRD, end-stage renal disease; Cr, creatinine.
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APPENDIX II, online only. Procedure related
demographic data
Procedure demographic No. of patients %
Hospital DTEP was performed
MMC 249 82.2
SJH 54 17.8
Time of day
AM 202 66.7
PM 101 33.3
Patient status
Outpatient 234 77.2
Inpatient 69 22.8
Study urgency
Elective 270 89.1
Urgent/emergent 33 10.9
Primary surgeon
1st year fellow 181 59.7
2nd year fellow 25 8.3
Visiting (3 month) fellow 72 23.8
Faculty scrubbed during case
Yes 194 64.0
No 109 36.0
DTEP, Diagnostic or therapeutic endovascular procedure; MMC, Memorial
Medical Center; SJH, St. John’s Hospital.
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APPENDIX III, online only. Indications for
performing AIF and AA studies
Indication No. of patients %
AIF
Claudication 63 32.3
Tissue loss 61 31.2
Aortic aneurysm 29 14.9
Rest pain 22 11.3
Impending graft failure 9 4.6
Acute ischemia 4 2.1
Endoleak evaluation 4 2.1
Trauma 2 1.0
Pseudoaneurysm 1 0.5
AA
Asymptomatic carotid disease 24 53.3
TIA 8 17.8
Upper extremity disease 5 11.1
CVA 3 6.7
Trauma 3 6.7
Carotid body tumor 1 2.2
Vertebral-basilar insufficiency 1 2.2
AIF, Abdominal aortogram with or without adjunctive lower extremity
arteriography; AA, arch aortography with carotid and/or upper extremity
arteriography; TIA, transient ischemic attack; CVA, cerebrovascular acci-
dent.
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APPENDIX IV, online only. Diagnostic and
therapeutic endovascular procedure details
Arterial access site
(number)
Mean sheath size
(F)
Mean number of
exchanges
Right femoral 5.6  0.9 0.42  0.70
Left femoral 6.1  1.9 0.59  0.74
Left brachial 5.7  1.9 0.44  0.70
Left axillary 5 1
Bypass graft 5.7  0.6 0.43  0.68
Dialysis fistula 5.8  1.2 0.52  0.64
Venous access site
(number)
Right femoral 7.5  2.4 0.73  0.59
Left axillary 5 0
Jugular 5.9  0.3 0.91  0.54
Cephalic 5.7  0.6 0.91  0.54
Popliteal 1 0
Catheterizations Nonselective Selective
Patient number 85 218
First order 103
Second order 83
Third order 51
Contrast used
during DTEP
Nonionic 301
Gadolinium 2
Carbon dioxide 1
None 1
Contrast amount*
Mean DEP 147  66 mL
Mean TEP 160  79 mL
Fluoroscopy times†
Mean DTEP 9  14 minutes
Mean DEP 8  7
Mean TEP 19  14
Anticoagulation
administered
Heparin 258 patients Mean dose
3677  1600
Protamine 42 patients
DTEP, Diagnostic and therapeutic endovascular procedure.
*No significant differences between DEPs and TEPs.
†TEP significantly greater than DEP, P  .001
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